AstraZeneca doubles capacity for potential Covid-19 vaccine to 2bn doses

Company will increase manufacturing capability after striking additional deal worth £595m

AstraZeneca has doubled the manufacturing capacity for its potential Covid-19 vaccine to 2bn doses after striking a number of deals that include two health organisations backed by Bill and Melinda Gates.

Last month the pharmaceutical giant said it could manufacture 1bn doses of the vaccine that it is developing in partnership with with researchers at Oxford University.

Continue reading…
Company will increase manufacturing capability after striking additional deal worth £595mCoronavirus – latest updatesSee all our coronavirus coverageAstraZeneca has doubled the manufacturing capacity for its potential Covid-19 vaccine to 2bn doses after striking a number of deals that include two health organisations backed by Bill and Melinda Gates.Last month the pharmaceutical giant said it could manufacture 1bn doses of the vaccine that it is developing in partnership with with researchers at Oxford University. Continue reading…

Pharmaceuticals industry, World news, Coronavirus outbreak, Bill Gates

Be the first to comment on "AstraZeneca doubles capacity for potential Covid-19 vaccine to 2bn doses"

Leave a comment

Your email address will not be published.


*